Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes.

Journal:

Diabetes Care

Published:

2025-11-14

DOI:

10.2337/dc25-1031

Affiliations:

4

Authors:

6

Go to article

Institutions	Authors	Share
Hebrew SeniorLife (HSL), United States of America (USA)	3.666667	0.61
Harvard Medical School (HMS), United States of America (USA)	1.166667	0.19
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	0.666667	0.11
Ramathibodi Hospital, MU, Thailand	0.500000	0.08

Interested in Clinical Sciences?